This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08233/identifier/chemspider/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB08233/identifier/pdb/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://linked.opendata.cz/resource/drugbank/drug/DB08233/identifier/pubchem-compound/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08233/identifier/pubchem-substance/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB08233/identifier/drugbank/

Statements

Subject Item
n2:DB08233
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB08233 n14:DB08233
dcterms:title
6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE
adms:identifier
n9:99444704 n10:N20 n11:447649 n12:394681 n13:DB08233
n3:IUPAC-Name
n4:271B443D-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4443-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4442-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B443F-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4440-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4441-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B443B-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4439-363D-11E5-9242-09173F13E4C5 n4:271B443C-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B443A-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4449-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B444A-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4444-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4445-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4447-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4446-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4448-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B444F-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4451-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4452-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B444E-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B444D-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4450-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B443E-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B444B-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B444C-363D-11E5-9242-09173F13E4C5